Observational studyRevista medica del Instituto Mexicano del Seguro Social2026
[Initial clinical experience with ribociclib in advanced HR+/HER2- breast cancer in Uruguay].
Natalia Camejo-Martínez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.